Versant Venture Management as of Dec. 31, 2016
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Audentes Therapeutics | 32.1 | $33M | 1.8M | 18.27 | |
| Ocular Therapeutix (OCUL) | 18.1 | $19M | 2.2M | 8.37 | |
| Clovis Oncology | 17.6 | $18M | 407k | 44.42 | |
| Achaogen | 16.2 | $17M | 1.3M | 13.02 | |
| Immune Design | 11.8 | $12M | 2.2M | 5.50 | |
| Glaukos (GKOS) | 2.4 | $2.4M | 71k | 34.30 | |
| Cymabay Therapeutics | 1.8 | $1.8M | 1.0M | 1.73 |
